NDC product
Metoclopramide
NDC 62559-295 · ANI Pharmaceuticals, Inc.
Key facts
| Product NDC | 62559-295 |
|---|---|
| Proprietary name | Metoclopramide |
| Nonproprietary name | Metoclopramide |
| Substances | METOCLOPRAMIDE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | ANI Pharmaceuticals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA017854 |
| Pharmacologic classes | Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC] |
| Marketing start | Dec 13, 2021 |
| Marketing end | May 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory